Hartford HealthCare
Hartford, Connecticut, United States
Hospital in Hartford, Connecticut
80 Seymour St, Hartford, CT 06106
867 Beds
About Hartford HealthCare
Hartford Hospital is an 938-bed acute care teaching hospital located in the South End of Hartford, Connecticut. Hartford Hospital was established in 1854. The hospital campus is located on Seymour Street in Hartford and is directly adjacent to the main campus of the Connecticut Children's Medical Center.
There are 867 beds in Hartford HealthCare.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Memorial Sloan Kettering Cancer Center
3
Regeneron Pharmaceuticals
2
Aadi Bioscience, Inc.
1
Abiomed Inc.
1
Ancora Heart, Inc.
1
Artoss Inc.
1
Astellas Pharma Global Development, Inc.
1
Craig L Slingluff, Jr
1
Critical Care Pharmacotherapy Trials Network
1
Curegenix Inc.
1
Endospan Ltd.
1
Clinical Trials at Hartford HealthCare
During the past decade, Hartford HealthCare conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 1 clinical trials were completed, i.e. on
average, 4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
2015-03-01
2022-12-01
Recruiting
68
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
2016-02-01
2023-03-01
Recruiting
72
Drug Resistance Factors In Healthcare-associated Pneumonia
2016-11-01
2017-02-28
Completed
679
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
2017-12-21
2021-06-28
Terminated
685
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
2017-12-19
2022-07-19
Completed
408
A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
2018-03-07
2019-02-05
Completed
385
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
2018-10-01
2023-10-01
Recruiting
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hartford HealthCare" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 3 trials, followed by "Regeneron Pharmaceuticals" with 2 trials
sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored, "Abiomed Inc." with 1 trials sponsored and "Ancora Heart, Inc."
with 1 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford HealthCare"
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Hartford HealthCare
According to Clinical.Site data, the most researched conditions in "Hartford HealthCare" are
"Metastatic Cancer" (4 trials), "Melanoma" (3 trials), "Advanced Cancer" (2 trials), "Advanced Melanoma" (2 trials) and "Metastatic Melanoma" (2 trials). Many other conditions were trialed in "Hartford HealthCare" in a lesser frequency.
Clinical Trials Intervention Types at Hartford HealthCare
Most popular intervention types in "Hartford HealthCare" are "Drug" (14 trials), "Device" (5 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (3 trials), "CMP-001" (2 trials), "Nivolumab" (2 trials), "ASP9801" (1 trials) and "AccuCinch Ventricular Restoration System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hartford HealthCare
The vast majority of trials in "Hartford HealthCare" are
24 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hartford HealthCare
Currently, there are NaN active trials in "Hartford HealthCare".
undefined are not yet recruiting,
15 are recruiting,
3 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 4 completed trials in Hartford HealthCare,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hartford HealthCare, 3 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".
Departments of Hartford HealthCare
Hartford HealthCare has several departments that took part in Clinical trials: "Hartford Hospital Cancer Clinical Research Office" - 4 trials
Departments List
Name
City
Trials